webinar register page

Webinar banner
Pathology, Pathogenesis, and Implications for Treatment and Outcomes in COVID-19 Patients
This webinar will address the following:
1) The pathogenesis of SARS-CoV-2 disease based on properties of the virus and susceptibility factors in the host which influence the severity of disease
2) Disease expression in lungs, heart, and other organ systems
3) Mainline therapy for hypoxic respiratory failure
4) Rationale for potential adjunctive therapeutic options, including antivirals, antibodies, anti-inflammatory agents, targeted immunomodulatory therapies, anticoagulants, and antifibrotics
5) Vaccine development and prevention

Aug 19, 2020 11:30 AM in Eastern Time (US and Canada)

Webinar logo
* Required information


L. Maximilian Buja, MD
Professor of Pathology and Laboratory Medicine @McGovern Medical School of the University of Texas Health Science Center at Houston
Dr. Buja is Professor of Pathology and Laboratory Medicine and Distinguished Teaching Professor at the McGovern Medical School of the University of Texas Health Science Center at Houston. His scholarly focus is on pathogenesis of cardiovascular diseases. He is an advocate of the importance of the autopsy in medicine and has written several timely articles advocating for the autopsy. Dr. Buja joined ASIP as a resident, and has remained a committed member for around 4 decades now. Thank you for you loyal membership, Dr. Buja. It goes a long way to advise us all, especially, the young professionals to identify relevant organizations for our professional development.
Chhavi Chauhan, PhD, ELS
Director of Scientific Outreach/JMD CME Program @American Society for Investigative Pathology
Chhavi Chauhan is a passionate researcher who transitioned into scholarly publishing to effectively communicate dense science to masses. She completed her undergrad in Chemistry from Hansraj College, New Delhi, India; Master’s in Biotechnology from Maharaja SayajiRao University, Vadodara, India; and PhD in Molecular Biology for Loyola University of Chicago, Chicago, IL. She got her post-doctoral training at the prestigious National Cancer Institute (NCI), Frederick, MD. After a brief post-doc at the NCI, she joined as Scientific Editor for The American Journal of Pathology and The Journal of Molecular Diagnostics. She is currently Director of Scientific Outreach and the JMD CME Program at the American Society for Investigative Pathology.